GenMont Biotech Incorporation
Research GenMont Biotech Incorporation (3164.TW) on Bullrun: market cap TWD 1.44B, P/E 21.0, dividend yield 4.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3164.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 1.44B
- P/E21.0
- Dividend yield4.8%
- Financial periodQ2 2026
- RevenueTWD 103.33M
- Net incomeTWD 15.54M
- Free cash flowTWD 26.01M
- Gross margin59.1%
Valuation Snapshot
latest market cap is TWD 1.44B; P/E is 21.0; dividend yield is 4.8%.
Peer valuation comparison
Latest P/E is 21x versus a Healthcare sector median of 21.74x (3.4% below).
Latest dividend yield is 4.76% versus a Healthcare sector median of 2.4% (98.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | TWD 1.44B | 21.0 | 4.8% | 0.8 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.8 TWD, yield 4.8%.
About GenMont Biotech Incorporation
GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GenMont Biotech Incorporation's market cap?
GenMont Biotech Incorporation's market capitalization is TWD 1.44B.
What is GenMont Biotech Incorporation's P/E ratio?
GenMont Biotech Incorporation's price-to-earnings (P/E) ratio is 21.0.
Does GenMont Biotech Incorporation pay a dividend?
GenMont Biotech Incorporation has a dividend yield of 4.8%.
What does GenMont Biotech Incorporation do?
GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan.